NCT03755544View on ClinicalTrials.gov

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

February 13, 2020

Study Completion Date

February 13, 2020

Conditions
AsthmaChronic Obstructive Pulmonary Disease
Trial Locations (1)

Unknown

Lungenpraxis, Hamburg

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03755544 - Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD | Biotech Hunter | Biotech Hunter